1 completed, 1 recruiting, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
Follow Magnetic Resonance Imaging of the Brain with and without Contrast: new trials by email Literature Review of Magnetic Resonance Imaging of the Brain with and without Contrast trials Research Report on Magnetic Resonance Imaging of the Brain with and without Contrast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma Azeliragon, Biospecimen Collection, Computed Tomography - Glioblastoma, Malignant Glioma | Phase 1 | Withdrawn | City of Hope Medical Center | 2024-11-15 | 2024-09-19 | |
| Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer Carboplatin, Durvalumab, Paclitaxel - Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | Phase 1 | Recruiting | Ohio State University Comprehensive Cancer Center | 28 | 2021-12-06 | 2026-06-30 |
| Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial Accelerated Hypofractionated Radiation Therapy, Biospecimen Collection, Computed Tomography - Locally Advanced Lung Non-Small Cell Carcinoma, Locally Recurrent Lung Non-Small Cell Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 26 | 2019-10-28 | 2025-09-23 |
Lung Neoplasms (2) · Glioblastoma (1) · Glioma (1)
City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1)
United States (2)
Jana L Portnow (1) · Jeremey Brownstein, MD (1) · Steven H Lin (1)
P30CA033572 (1), R01CA262388 (1), U10CA180868 (1), U19CA264512 (1)